Karo Pharma AB Stock
Karo Pharma AB Stock
With 7 Buy predictions and not the single Sell prediction the community is currently very high on Karo Pharma AB.
With a target price of 50 € there is potential for a 819.12% increase which would mean more than doubling the current price of 5.44 € for Karo Pharma AB.
Pros and Cons of Karo Pharma AB in the next few years
Pros
?
M***** P*******
?
S********** s********
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karo Pharma AB vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Karo Pharma AB | - | - | - | - | - | - | - |
| Medivir AB | - | 129.730% | -8.356% | -83.654% | -84.332% | -96.145% | -95.948% |
| Active Biotech AB | -4.170% | 41.176% | -36.842% | 4700.000% | -66.897% | -94.353% | -96.496% |
| Actinium Pharmaceuticals Inc. | 0.810% | 4.739% | 14.159% | 1.989% | 11.381% | -87.218% | -86.505% |
Comments
Karooooo (NASDAQ:KARO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo (NASDAQ:KARO) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "strong-buy" rating.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James Financial, Inc.. They now have a $60.00 price target on the stock, up previously from $58.00.
Show more
Ratings data for KARO provided by MarketBeat